Can a vaccine boost immunotherapy against a stubborn cancer?
Disease control
Completed
This phase II trial is testing whether a cancer vaccine called PolyPEPI1018, when combined with the immunotherapy drug atezolizumab, can help people with a specific type of metastatic colorectal cancer that has not responded to previous treatments. The study enrolls adults with m…
Phase: PHASE2 • Sponsor: Treos Bio Limited • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC